|Daily Range||$44.74 - $45.55|
|52-Week Range||$40.10 - $47.50|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||518,005|
|Current FY EPS||$2.06|
Looking for health-care exposure in your portfolio, but want to steer clear of the Obamacare debate? Then this little-known health-care industry could be the answer.
Contract Researchers have taken it on the chin following Parexel's (PRXL) lackluster quarterly results. But that view might be short sighted given drug makers are increasingly turning to CROs to usher drugs through trials.